Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Seizure Drug Gabapentin May Boost Survival for Brain Cancer Patients

Daniel Kim Views  

Shutterstock
Shutterstock

According to a study published in Nature Communications, gabapentin, an anticonvulsant and pain reliever, is linked to higher survival rates for glioblastoma patients.

Glioblastoma is one of the most deadly and aggressive types of brain cancer. It is known to be the primary cause of most adult primary brain tumors, with approximately 12,000 new cases reported annually in the United States.

The majority of patients live only 12 to 14 months after diagnosis and 5.5 months after recurrence, and the overall survival rate has hardly changed over the past few decades. The research team examined the treatment outcomes of 693 glioblastoma patients, most of whom were taking gabapentin for neuralgia.

According to the study, patients who took the medication lived an average of 16 months, while those who did not lived an average of 12 months. In another cohort study involving 379 glioblastoma patients, those who took gabapentin lived an average of 20.8 months, compared to 14.7 months for those who did not. The researchers concluded that gabapentin use might increase glioblastoma patients’ chances of survival.

However, to confirm the impact of gabapentin administration on the survival rate of glioblastoma, the researchers noted that these studies were retrospective and that a larger prospective cohort study is required.

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[LIFESTYLE] Latest Stories

  • Why Your Eyelid Keeps Twitching—and When to Worry
  • Silent Spreaders: How Measles Can Infect Before Symptoms Appear
  • Eat More Eggplant—It’s Good for Your Blood and Your Heart
  • Want to Burn More Fat? Try a 30-Second Cold Shower, Experts Say
  • Bats, Fruit, and a Deadly Virus—Why Korea’s Health Officials Are on High Alert
  • Why You Crave Junk Food When You’re Sad—And What to Eat Instead

You May Also Like

  • 1
    Trump Claims Epstein 'Stole' Young Women from Mar-a-Lago Spa

    LATEST 

  • 2
    Say Hello to Your New Beauty Buddy: AI-Powered Kiosks Hit GS25 Stores!

    LATEST 

  • 3
    New Task Force Takes Aim at Stock Manipulators: A Game Changer for Investors!

    LATEST 

  • 4
    COP30 Chaos: Will Brazil's Soaring Hotel Prices Keep Poor Nations Out of Climate Talks?

    LATEST 

  • 5
    Is Tesla Behind LG Energy's Massive Battery Supply Contract?

    LATEST 

Popular Now

  • 1
    Taiwan's President Delays Trip to the Americas Amid Typhoon Chaos

    LATEST 

  • 2
    Hydroleap Secures $4.75 Million to Revolutionize Water Treatment in Asia!

    LATEST 

  • 3
    Enhypen's New Single 'Yoi' Soars to the Top, Selling Over 300,000 Copies on Day One!

    LATEST 

  • 4
    Chanyeol of EXO Set to Drop Solo Album This August – Here’s What We Know!

    LATEST 

  • 5
    Caught Between Borders: Texas Man's Harrowing Eight-Day Detention

    LATEST 

Must-Reads

  • 1
    Trump Claims Epstein 'Stole' Young Women from Mar-a-Lago Spa

    LATEST 

  • 2
    Say Hello to Your New Beauty Buddy: AI-Powered Kiosks Hit GS25 Stores!

    LATEST 

  • 3
    New Task Force Takes Aim at Stock Manipulators: A Game Changer for Investors!

    LATEST 

  • 4
    COP30 Chaos: Will Brazil's Soaring Hotel Prices Keep Poor Nations Out of Climate Talks?

    LATEST 

  • 5
    Is Tesla Behind LG Energy's Massive Battery Supply Contract?

    LATEST 

Popular Now

  • 1
    Taiwan's President Delays Trip to the Americas Amid Typhoon Chaos

    LATEST 

  • 2
    Hydroleap Secures $4.75 Million to Revolutionize Water Treatment in Asia!

    LATEST 

  • 3
    Enhypen's New Single 'Yoi' Soars to the Top, Selling Over 300,000 Copies on Day One!

    LATEST 

  • 4
    Chanyeol of EXO Set to Drop Solo Album This August – Here’s What We Know!

    LATEST 

  • 5
    Caught Between Borders: Texas Man's Harrowing Eight-Day Detention

    LATEST 

Share it on...